Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (FY)Jun 30, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | 68.95%10.6M | 10.52M | 64K | -4.67%6.27M | 19.22%6.58M | -7.46%5.52M | 5.96M | 72.52%115.68K | ||
| Revenue from customers | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 65.15%2.03K |
| Income from government grants | -81.75%25K | ---- | ---- | -50.54%137K | -39.23%277K | 1,591.37%455.81K | --26.95K | ---- | ---- | ---- |
| Other cash income from operating activities | -16.67%175K | ---40K | --64K | 5,150.00%210K | -95.59%4K | -11.98%90.68K | --103.03K | ---- | ---- | 72.66%113.65K |
| Cash paid | -2.57%-174.95M | -43.58M | -43.37M | -30.90%-170.56M | -69.07%-130.29M | -48.50%-77.06M | -51.89M | -211.43%-15.33M | ||
| Payments to suppliers for goods and services | -2.40%-174.65M | ---- | ---- | -30.90%-170.56M | -69.07%-130.29M | -48.50%-77.06M | ---51.89M | ---- | ---- | -149.08%-17.32M |
| Cash paid on behalf of employees | ---- | ---- | ---4.26M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other cash payments from operating activities | ---- | ---- | ---39.11M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Direct interest paid | -33.33%-8K | ---1K | ---2K | 64.71%-6K | -187.16%-17K | -2.39%-5.92K | ---5.78K | ---- | ---- | ---- |
| Direct interest received | 74.40%5.72M | --1.68M | --2.12M | 4.96%3.28M | 1,342.55%3.12M | -44.53%216.42K | --390.13K | ---- | ---- | 170.98%569.02K |
| Direct tax refund paid | 70.40%10.1M | --10.32M | --0 | -5.92%5.93M | 26.67%6.3M | -14.76%4.97M | --5.83M | ---- | ---- | -2.01%1.99M |
| Operating cash flow | 1.47%-158.64M | ---31.38M | ---41.19M | -33.50%-161.02M | -69.07%-120.61M | -56.62%-71.33M | ---45.55M | ---- | ---- | -215.26%-14.65M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 60.61%-13K | -2K | -11K | -50.00%-33K | -30.10%-22K | -102.58%-16.91K | 97.01%656.48K | 38.93%333.22K | 1,048.65%239.84K | -119.52%-25.28K |
| Net PPE purchase and sale | 60.61%-13K | ---2K | ---11K | -50.00%-33K | -30.10%-22K | -33.13%-16.91K | -401.86%-12.7K | 75.66%-2.53K | 58.87%-10.4K | -969.24%-25.28K |
| Net investment purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | 99.31%669.18K | 34.17%335.75K | --250.24K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 60.61%-13K | ---2K | ---11K | -50.00%-33K | -30.10%-22K | -102.58%-16.91K | 97.01%656.48K | 38.93%333.22K | 1,048.65%239.84K | -119.52%-25.28K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -85.74%34.77M | 7K | 34.77M | 45.70%243.73M | 97,387.14%167.29M | -99.85%171.6K | 252.54%116.94M | 265.73%33.17M | 2,146.23%9.07M | -98.79%403.77K |
| Net issuance payments of debt | -4.49%-93K | ---55K | --0 | -25.35%-89K | 17.03%-71K | 2.05%-85.58K | -30.84%-87.37K | ---66.78K | --0 | ---- |
| Net common stock issuance | -78.08%34.81M | --0 | --34.8M | 94.12%158.82M | --81.82M | --0 | 220.10%105.48M | 263.32%32.95M | 2,146.23%9.07M | -98.85%403.77K |
| Proceeds from stock option exercised by employees | --51K | ---- | ---- | --0 | 304.78%1.04M | -97.77%257.18K | 3,953.68%11.55M | --284.83K | --0 | ---- |
| Net other financing activities | ---- | --32K | ---31K | 0.59%85M | --84.5M | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -85.74%34.77M | --8K | --34.77M | 45.70%243.73M | 97,387.14%167.29M | -99.85%171.6K | 252.54%116.94M | 265.73%33.17M | 2,146.23%9.07M | -98.79%403.77K |
| Net cash flow | ||||||||||
| Beginning cash position | 93.38%172.47M | --167.51M | --172.47M | 99.84%89.19M | -62.24%44.63M | 177.12%118.19M | 182.05%42.65M | -37.20%15.12M | -36.91%24.08M | 242.88%38.17M |
| Current changes in cash | -249.84%-123.89M | ---31.38M | ---6.43M | 77.22%82.68M | 165.54%46.66M | -198.80%-71.18M | 159.04%72.05M | 459.69%27.81M | 45.80%-7.73M | -149.47%-14.27M |
| Effect of exchange rate changes | -122.96%-138K | ---4.22M | --1.47M | 128.66%601K | 11.95%-2.1M | -168.13%-2.38M | 1,329.62%3.5M | 76.81%-284.3K | -5,999.44%-1.23M | 56.20%-20.1K |
| End cash Position | -71.91%48.44M | --131.92M | --167.51M | 93.38%172.47M | 99.84%89.19M | -62.24%44.63M | 177.12%118.19M | 182.05%42.65M | -36.68%15.12M | -40.19%23.88M |
| Free cash from | 1.48%-158.66M | ---31.38M | ---41.2M | -33.51%-161.05M | -69.06%-120.63M | -56.61%-71.35M | -700.38%-45.56M | 66.62%-5.69M | -16.23%-17.05M | -215.65%-14.67M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | Unqualified Opinion | Unqualified Opinion with Explanatory Notes | -- | -- | -- |